These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28152251)

  • 21. Role of apparent diffusion coefficient values in prostate diseases characterization on diffusion-weighted magnetic resonance imaging.
    Salvaggio G; Calamia M; Purpura P; Bartolotta TV; Picone D; Dispensa N; Lunetta C; Bruno A; Raso L; Salvaggio L; Lo Re G; Galia M; Simonato A; Midiri M; Lagalla R
    Minerva Urol Nefrol; 2019 Apr; 71(2):154-160. PubMed ID: 30421590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
    Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
    AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion-weighted MRI and PSA correlations in patients with prostate cancer treated with radiation and hormonal therapy.
    Iraha Y; Murayama S; Kamiya A; Iraha S; Ogawa K
    Anticancer Res; 2012 Oct; 32(10):4467-71. PubMed ID: 23060574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anterior Prostate Cancer: Diagnostic Performance of T2-Weighted MRI and an Apparent Diffusion Coefficient Map.
    Shinmoto H; Tamura C; Soga S; Okamura T; Horiguchi A; Asano T; Kaji T
    AJR Am J Roentgenol; 2015 Aug; 205(2):W185-92. PubMed ID: 26204306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations.
    Reischauer C; Froehlich JM; Koh DM; Graf N; Padevit C; John H; Binkert CA; Boesiger P; Gutzeit A
    Radiology; 2010 Nov; 257(2):523-31. PubMed ID: 20829534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
    Kim CK; Park BK; Lee HM
    J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of mean apparent diffusion coefficient measured with diffusion-weighted magnetic resonance image in patients with prostate cancer treated with definitive radiotherapy.
    Onal C; Erbay G; Guler OC; Oymak E
    Radiother Oncol; 2022 Aug; 173():285-291. PubMed ID: 35753556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion in prostate cancer detection on a 3T scanner: How many b-values are needed?
    de Perrot T; Scheffler M; Boto J; Delattre BM; Combescure C; Pusztaszeri M; Tille JC; Iselin C; Vallée JP
    J Magn Reson Imaging; 2016 Sep; 44(3):601-9. PubMed ID: 26914964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
    Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
    J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haralick textural features on T
    Gnep K; Fargeas A; Gutiérrez-Carvajal RE; Commandeur F; Mathieu R; Ospina JD; Rolland Y; Rohou T; Vincendeau S; Hatt M; Acosta O; de Crevoisier R
    J Magn Reson Imaging; 2017 Jan; 45(1):103-117. PubMed ID: 27345946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted imaging of prostate cancer on 3T MR: Relationship between apparent diffusion coefficient values and Ki-67 expression.
    Zhang J; Jing H; Han X; Huang Z; Cao Z; Liu Q
    Acad Radiol; 2013 Dec; 20(12):1535-41. PubMed ID: 24200480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of the apparent diffusion coefficient for the early prediction of the treatment response after definitive radiotherapy in prostate cancer patients.
    Onal C; Erbay G; Oymak E; Guler OC
    Radiother Oncol; 2023 Jul; 184():109677. PubMed ID: 37084886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
    Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
    Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer.
    Foltz WD; Wu A; Chung P; Catton C; Bayley A; Milosevic M; Bristow R; Warde P; Simeonov A; Jaffray DA; Haider MA; Ménard C
    J Magn Reson Imaging; 2013 Apr; 37(4):909-16. PubMed ID: 23097411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The correlation between biological activity and diffusion-weighted MR imaging and ADC value in cases with prostate cancer.
    Sokmen BK; Sokmen D; Ucar N; Ozkurt H; Simsek A
    Arch Ital Urol Androl; 2017 Dec; 89(4):277-281. PubMed ID: 29473377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravoxel Incoherent Motion (IVIM) Diffusion Weighted Imaging (DWI) in the Periferic Prostate Cancer Detection and Stratification.
    Pesapane F; Patella F; Fumarola EM; Panella S; Ierardi AM; Pompili GG; Franceschelli G; Angileri SA; Magenta Biasina A; Carrafiello G
    Med Oncol; 2017 Mar; 34(3):35. PubMed ID: 28144814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion-weighted magnetic resonance imaging in patients with prostate cancer treated with radiotherapy.
    Iannelli G; Caivano R; Rago L; Simeon V; Lotumolo A; Rabasco P; Villonio A; Gioioso M; Mastrangelo P; Barchetti F; Panebianco V; Macarini L; Guglielmi G; Cammarota A
    Tumori; 2016; 102(1):71-6. PubMed ID: 26350197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: preliminary experience.
    Park SY; Kim CK; Park BK; Kwon GY
    AJR Am J Roentgenol; 2014 Sep; 203(3):W287-94. PubMed ID: 25148186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracapsular extension in prostate cancer: added value of diffusion-weighted MRI in patients with equivocal findings on T2-weighted imaging.
    Woo S; Cho JY; Kim SY; Kim SH
    AJR Am J Roentgenol; 2015 Feb; 204(2):W168-75. PubMed ID: 25615777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.